Article

Cancer T-cell therapy: building the foundation for a cure

2020-12-22

Abstract excerpt

T-cell cancer therapy is a clinical field flush with opportunity. It is part of the revolution in immuno-oncology, most apparent in the dramatic clinical success of PD-1/CTLA-4 antibodies and chimeric antigen receptor T-cells (CAR-Ts) to cure certain melanomas and lymphomas, respectively. Therapeutics based on T cells ultimately hold more promise because of their capacity to carry out complex behaviors and their...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 40d94100-0977-5ba7-b259-58ce29a31bde
DOI: 10.12688/f1000research.27217.2

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Cancer T-cell therapy: building the foundation for a cureDOI 10.12688/f1000research.27217.2Read

The Anticancer Potential of T Cell Receptor-Engineered T Cells.Semantic proximity Read

Engineering T Cells to Treat Cancer: The Convergence of Immuno-Oncology and Synthetic BiologySemantic proximity Read

CAR T Cell Therapy: A Versatile Living DrugSemantic proximity Read

From molecular design to clinical translation: dual-targeted CAR-T strategies in cancer immunotherapySemantic proximity Read

The labyrinthine ways of cancer immunotherapy--T cell, tumor cell encounter: "how do I lose thee? Let me count the ways".Semantic proximity Read

T cell receptor‐based cancer immunotherapy: Emerging efficacy and pathways of resistanceSemantic proximity Read

Chimeric Antigen Receptor (CAR) T Cells: A Detailed Review of Origins, Engineering, and Therapeutic ImpactSemantic proximity Read

CAR T-cell Therapy: A New Era in Cancer ImmunotherapySemantic proximity Read

Engineering chimeric antigen receptor-T cells for cancer treatment.Semantic proximity Read

Emerging Cellular Therapies for CancerSemantic proximity Read

Off-the-shelf CAR T cells to treat cancerSemantic proximity Read

CAR–T cells and solid tumors: tuning T cells to challenge an inveterate foeSemantic proximity Read